Low molecular weight heparin for the prevention of severe preeclampsia: where next?
Kelsey McLaughlinRalph R ScholtenJohn D ParkerEnrico FerrazziJohn C P KingdomPublished in: British journal of clinical pharmacology (2018)
Low molecular weight heparin has been extensively evaluated for the prevention of preeclampsia in high-risk pregnant women; however, the results from these trials have been conflicting. This review discusses the potential mechanisms of action of low molecular weight heparin for the prevention of severe preeclampsia, how to optimize the selection of high-risk women for participation in future trials, and the importance of trial standardization.